日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Left Atrial Remodeling Identification and Catheter Ablation Outcomes With (18)F-Fluorodeoxyglucose Positron Emission Tomography in Persistent Atrial Fibrillation

持续性房颤患者左心房重构的识别及导管消融疗效:(18)F-氟代脱氧葡萄糖正电子发射断层扫描的应用

Raoult, Tristan; Gerber, Bernhard L; Garnir, Quentin; Scavée, Christophe; Varnavas, Varnavas; Wauters, Aurélien; Gruson, Damien; Nellessen, Eric; Hesse, Michel; Beauloye, Christophe; Roelants, Véronique; Marchandise, Sébastien

Left Atrial Glucose Metabolism Evaluation by (18)F-FDG-PET in Persistent Atrial Fibrillation and in Sinus Rhythm

持续性房颤和窦性心律患者左心房葡萄糖代谢的(18)F-FDG-PET评估

Marchandise, Sébastien; Roelants, Véronique; Raoult, Tristan; Garnir, Quentin; Scavée, Christophe; Varnavas, Varnavas; Wauters, Aurélien; Gruson, Damien; Nellessen, Eric; Hesse, Michel; Beauloye, Christophe; Gerber, Bernhard L

Tgif1-deficiency impairs cytoskeletal architecture in osteoblasts by activating PAK3 signaling

Tgif1 缺乏会激活 PAK3 信号,从而损害成骨细胞的细胞骨架结构

Simona Bolamperti, Hiroaki Saito, Sarah Heerdmann, Eric Hesse #, Hanna Taipaleenmäki #

Multiscale molecular profiling of pathological bone resolves sexually dimorphic control of extracellular matrix composition

病理骨的多尺度分子分析解决了细胞外基质组成的性别二态控制

Aikta Sharma, Alice Goring, Peter B Johnson, Roger J H Emery, Eric Hesse, Alan Boyde, Bjorn R Olsen, Andrew A Pitsillides, Richard O C Oreffo, Sumeet Mahajan, Claire E Clarkin

Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals

罗莫索单抗联合抗骨吸收治疗可提高达到骨矿物质密度治疗目标的概率

Cosman, Felicia; Libanati, Cesar; Deignan, Cynthia; Yu, Zhigang; Wang, Zhenxun; Ferrari, Serge; Beck Jensen, Jens-Erik; Peris, Pilar; Bertoldo, Francesco; Lespessailles, Eric; Hesse, Eric; Cummings, Steven R

Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss

成熟成骨细胞/骨细胞中的甲状旁腺激素信号可保护小鼠免于与年龄相关的骨质流失

Yuhei Uda, Vaibhav Saini, Christopher A Petty, Majed Alshehri, Chao Shi, Jordan M Spatz, Roberto Santos, Carly M Newell, Tim Y Huang, Alejandro Kochen, Ji W Kim, Christodoulos K Constantinou, Hiroaki Saito, Kathryn D Held, Eric Hesse, Paola Divieti Pajevic

Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment

Tgif1 缺乏的骨微环境中乳腺癌骨转移减弱

Marie-Therese Haider, Hiroaki Saito, Jennifer Zarrer, Kevin Uzhunnumpuram, Sankari Nagarajan, Vijayalakshmi Kari, Michael Horn-Glander, Stefan Werner, Eric Hesse, Hanna Taipaleenmäki

TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone

TG 相互作用因子 1 (Tgif1) 缺乏会减弱骨骼重塑并削弱对甲状旁腺激素的合成代谢反应

Hiroaki Saito, Andreas Gasser, Simona Bolamperti, Miki Maeda, Levi Matthies, Katharina Jähn, Courtney L Long, Hartmut Schlüter, Marcel Kwiatkowski, Vaibhav Saini, Paola Divieti Pajevic, Teresita Bellido, Andre J van Wijnen, Khalid S Mohammad, Theresa A Guise, Hanna Taipaleenmäki, Eric Hesse

Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness

硬化蛋白抑制可减轻乳腺癌引起的骨转移和肌肉无力

Eric Hesse, Saskia Schröder, Diana Brandt, Jenny Pamperin, Hiroaki Saito, Hanna Taipaleenmäki

Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities

可诱导足细胞特异性 CTCF 缺失导致肾脏疾病和骨骼异常

Marta Christov, Abbe R Clark, Braden Corbin, Samy Hakroush, Eugene P Rhee, Hiroaki Saito, Dan Brooks, Eric Hesse, Mary Bouxsein, Niels Galjart, Ji Yong Jung, Peter Mundel, Harald Jüppner, Astrid Weins, Anna Greka